News: A trend has been seen promoting a drink made by blending oats with water or juice, commonly referred to as “oatzempic.”
About Oatzempic
- Oatzempic is oat-based drink that people consume in the morning, often on an empty stomach for weight loss, appetite control or other health outcomes.
- The name references Ozempic, a prescription drug primarily prescribed for type 2 diabetes that is also known for its appetite-suppressing effects.
- The idea behind it is that Oats are rich in beta-glucan, a type of soluble fibre that forms a gel-like substance when mixed with water.
- This slows down digestion which helps you to feel full.
- There are no scientific studies that look at the “oatzempic drink” for weight loss, appetite control or other health outcomes.
About Ozempic
- Ozempic is a medication that contains the active ingredient semaglutide.
- Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists.
- Ozempic mimics the natural GLP-1 hormone that is released in the body after eating.
- How Ozempic Works
- Ozempic increases the release of insulin when blood sugar levels are high.
- It slows down stomach emptying, which helps people feel full for a longer period.
- Ozempic reduces the amount of sugar produced by the liver.
- These actions help improve blood sugar control and reduce appetite
- Medical Uses of Ozempic
- Ozempic is FDA-approved to help manage blood sugar levels (A1C) in adults with type 2 diabetes.
- It is used along with lifestyle changes such as a healthy diet and regular exercise.
- Ozempic helps lower the risk of heart attack, stroke, and death from heart or blood vessel problems in adults with type 2 diabetes and heart disease.
- It is approved to reduce the risk of kidney function decline in adults with type 2 diabetes and chronic kidney disease (CKD).
- Semaglutide has been shown in clinical trials to support weight loss and help maintain weight loss.
- Weight loss occurs because Ozempic controls appetite and promotes prolonged feelings of fullness.
